Danaher Corporation $DHR Shares Sold by Swedbank AB

Swedbank AB decreased its position in Danaher Corporation (NYSE:DHR) by 48.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 523,130 shares of the conglomerate’s stock after selling 485,921 shares during the quarter. Swedbank AB owned 0.07% of Danaher worth $99,185,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG increased its stake in Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares during the period. Maxi Investments CY Ltd acquired a new stake in Danaher during the 3rd quarter worth approximately $3,251,000. Defender Capital LLC. purchased a new position in Danaher in the 4th quarter valued at approximately $35,715,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Finally, CIBC Bancorp USA Inc. acquired a new position in shares of Danaher in the third quarter worth $17,480,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE:DHR opened at $194.17 on Wednesday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The firm has a market capitalization of $137.42 billion, a PE ratio of 37.56, a price-to-earnings-growth ratio of 2.47 and a beta of 0.79. The business’s fifty day moving average price is $179.65 and its 200 day moving average price is $199.92.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Royal Bank Of Canada initiated coverage on Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective on the stock. DZ Bank began coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Argus reduced their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Guggenheim lowered their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Finally, Wells Fargo & Company cut their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $233.52.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.